Specialty Pharmacies Archives | Frier Levitt

Frier Levitt is Successful in Reversing Readmission Denial

Brenna Sackman, Esq., Dae Y. Lee, Esq., Pharm.D CPBS and Steven L. Bennet, Esq. August 25, 2020

Frier Levitt successfully reversed a five year wait for readmission for an independent pharmacy into one of the largest Pharmacy Benefit Managers (“PBM”) pharmacy networks. More specifically, the pharmacy was terminated by the PBM in 2017 for... Read More

DEA Guidance for Pharmacies Amidst Looting During Civil Unrest

Payal Amin, Pharm.D., RPh, Esq. and Jonathan E. Levitt, Esq. June 25, 2020

If your pharmacy has been vandalized or looted in the recent riots that have affected many cities and towns across the country, depending on the issue, there may be a number of notifications that the pharmacy is required to make as it relates to the... Read More

PHARMACY PROVIDER ALERT: Pharmacies Should Be Aware of a New Trend Requiring Maintenance of a Copy of Member ID card

Jesse C. Dresser, Esq. and Payal Amin, Pharm.D., RPh, Esq. June 17, 2020

PBM audits often follow certain trends which vary and evolve. One potentially emerging trend Frier Levitt has observed is that pharmacies who are undergoing audits with certain PBMs, namely OptumRx, are being asked to provide an actual copy of the... Read More

Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Specialty Pharmacies

PHARMACY ALERT: HHS Issues Guidance on PREP Act Preemption of State and Local Laws that Prohibit Licensed Pharmacists From Ordering and Administering FDA-approved COVID-19 Tests

Christopher Caltavuturo, Esq. and Jonathan E. Levitt, Esq. June 16, 2020

On May 19, 2020, the Department of Health and Human Services (HHS) issued guidance clarifying whether the Public Readiness and Emergency Preparedness (PREP) Act preempts State licensing laws that restrict pharmacists and pharmacies from ordering and... Read More

Blue Cross Blue Shield Plans in Six States Sue CVS for “Systematic Prescription Overcharging”

Martha M. Rumore Pharm.D., Esq. and Jesse C. Dresser, Esq. June 15, 2020

On May 27, 2020, Blue Cross Blue Shield plans in Alabama, Florida, Minnesota, North Dakota, North Carolina and Kansas filed suit against CVS Pharmacy alleging an insurance fraud scheme involving overcharging for generic drugs for over a decade. ... Read More

Compounded Drug Distribution MOU Between FDA and the States

Martha M. Rumore Pharm.D., Esq. and John E. Morrone, Esq. June 3, 2020

The Food and Drug Administration (FDA) continues to make drug compounding a high priority and will enforce the requirements of the Drug Quality and Security Act (DQSA). On May 13, 2020, the FDA issued two letters, one denying a Citizen’s... Read More

Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Specialty Pharmacies

CVS Health Settles for $15.3 Million Over Improperly Dispensing Opioids and Other Controlled Substances

Payal Amin, Pharm.D., RPh, Esq., Jesse C. Dresser, Esq. and Kendra E. Pannitti, Esq. June 3, 2020

According to a recent Department of Justice (“DOJ”) announcement, CVS Health’s subsidiary, Omnicare, which provides pharmacy services to long-term care facilities, will pay $15.3 million to the United States to resolve allegations that it... Read More

Community, Retail Pharmacies | Life Sciences | Pain Management Compliance | Pharmacy Law | Specialty Pharmacies

N.Y. BlueCross BlueShield Sues Walgreens for “Systematic Prescription Overcharging”

Martha M. Rumore Pharm.D., Esq. and Jesse C. Dresser, Esq. May 29, 2020

A group of New York BlueCross BlueShield health plans have filed suit against Walgreens, the largest community pharmacy chain, in U.S. District Court for the Northern District of Illinois alleging Walgreens inflated usual and customary (U&C)... Read More

Pharmacy Alert: Galderma Suits and Manufacturer Copay Cards

Paul H. Juzdan, Esq. May 18, 2020

Last month, Frier Levitt posted an article (click here to view) regarding cases filed by Galderma Laboratories (“Galderma”) in federal court. Galderma is alleging that certain pharmacies have engaged in fraud by misusing Galderma’s... Read More

Prime and Express Scripts’ Joint Venture: What Pharmacies Need to Know

Brenna Sackman, Esq. and Steven L. Bennet, Esq. May 18, 2020

At the end of 2019, Prime Therapeutics, LLC (“Prime”) announced that it had entered into a three-year supply chain agreement with Express Scripts, Inc. (“ESI”) “to focus on enhancing pharmacy networks and pharmaceutical manufacturer... Read More

Blogs & Articles | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Specialty Pharmacies

Category: Specialty Pharmacies